Volkmar Lufft

1.0k total citations
18 papers, 813 citations indexed

About

Volkmar Lufft is a scholar working on Transplantation, Surgery and Nephrology. According to data from OpenAlex, Volkmar Lufft has authored 18 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Transplantation, 5 papers in Surgery and 5 papers in Nephrology. Recurrent topics in Volkmar Lufft's work include Renal Transplantation Outcomes and Treatments (6 papers), Organ Transplantation Techniques and Outcomes (3 papers) and Acute Kidney Injury Research (3 papers). Volkmar Lufft is often cited by papers focused on Renal Transplantation Outcomes and Treatments (6 papers), Organ Transplantation Techniques and Outcomes (3 papers) and Acute Kidney Injury Research (3 papers). Volkmar Lufft collaborates with scholars based in Germany, United States and France. Volkmar Lufft's co-authors include Haidar Maatouk, Norbert Klause, Atef Halabi, Thomas Philipp, Michael Becka, Dagmar Kubitza, Wolfgang Mueck, Heike Bruck, Volker Kliem and R. Brunkhorst and has published in prestigious journals such as Blood, American Journal of Kidney Diseases and Transplantation.

In The Last Decade

Volkmar Lufft

18 papers receiving 772 citations

Peers

Countries citing papers authored by Volkmar Lufft

Since Specialization

Citations

This map shows the geographic impact of Volkmar Lufft's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Volkmar Lufft with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Volkmar Lufft more than expected).

Fields of papers citing papers by Volkmar Lufft

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Volkmar Lufft. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Volkmar Lufft. The network helps show where Volkmar Lufft may publish in the future.

Co-authorship network of co-authors of Volkmar Lufft

This figure shows the co-authorship network connecting the top 25 collaborators of Volkmar Lufft. A scholar is included among the top collaborators of Volkmar Lufft based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Volkmar Lufft. Volkmar Lufft is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Pharmacokinetics of Teneligliptin in Subjects With Renal Impairment 2013 ·Clinical Pharmacology in Drug Development ·Atef Halabi, Haidar Maatouk, (unknown), (unknown), Volkmar Lufft, Norbert Klause	32
2	Effects of renal impairment on the pharmacokinetics, pharmacodynamics and safety of rivaroxaban, an oral, direct Factor Xa inhibitor 2010 ·British Journal of Clinical Pharmacology ·Dagmar Kubitza, Michael Becka, Wolfgang Mueck, Atef Halabi, Haidar Maatouk, Norbert Klause, Volkmar Lufft, (unknown), Thomas Philipp, Heike Bruck	334
3	Increased type IIA secretory phospholipase A2 expression contributes to oxidative stress in end-stage renal disease 2009 ·Journal of Molecular Medicine ·Markus van der Giet, Markus Tölle, Domenico Praticò, Volkmar Lufft, Mirjam Schuchardt, (unknown), Walter Zidek, Uwe J.F. Tietge	12
4	Effects of Renal Impairment on the Pharmacology of Rivaroxaban (BAY 59-7939) - An Oral, Direct, Factor Xa Inhibitor. 2006 ·Blood ·Atef Halabi, Haidar Maatouk, Norbert Klause, Volkmar Lufft, Dagmar Kubitza, Michael Zuehlsdorf, Michael Becka, Wolfgang Mueck, Rafael F. Schäfers, (unknown), Thomas Philipp, Heike Bruck	19
5	Cardiovascular morbidity and mortality in patients with diabetes mellitus type I after kidney transplantation: a case-control study 2004 ·Clinical Nephrology ·Volkmar Lufft, (unknown), H. J. Schlitt, R. Pichlmayr, R. Brunkhorst	19
6	IMPROVED SURVIVAL IN PATIENTS WITH TYPE 1 DIABETES MELLITUS AFTER RENAL TRANSPLANTATION COMPARED WITH HEMODIALYSIS 2003 ·Transplantation ·R. Brunkhorst, Volkmar Lufft, (unknown), Volker Kliem, (unknown), R. Pichlmayr	44
7	Kidney transplantation in children: impact of young recipient age on graft survival 2003 ·Nephrology Dialysis Transplantation ·Volkmar Lufft	8
8	Differential modulation of synthesis of human il-1 beta and il-1 receptor antagonist by cyclosporin a 2002 ·Transplantation Proceedings ·Volkmar Lufft, (unknown), Gerhard Lonnemann	2
9	Contrast media nephropathy: Intravenous CT angiography versus intraarterial digital subtraction angiography in renal artery stenosis: A prospective randomized trial 2002 ·American Journal of Kidney Diseases ·Volkmar Lufft, (unknown), Lüder Fels, (unknown), Günter Tusch, Michael Galanski, Christoph J. Olbricht	61
10	Angiography for renal artery stenosis: no additional impairment of renal function by angioplasty 2001 ·European Radiology ·Volkmar Lufft, (unknown), Lüder Fels, (unknown), Christoph J. Olbricht, Michael Galanski	6
11	RENAL TRANSPLANTATION IN OLDER ADULTS 2000 ·Transplantation ·Volkmar Lufft, Volker Kliem, (unknown), (unknown), R. Brunkhorst	53
12	Antiproteinuric efficacy of fosinopril after renal transplantation is determined by the extent of vascular and tubulointerstitial damage 1998 ·Clinical Transplantation ·Volkmar Lufft, Volker Kliem, (unknown), Jörg S. Bleck, Ute Eisenberger, Ruth Petersen, (unknown), H. Maschek, (unknown), R. Brunkhorst	30
13	Long-term results after primary successful FK 506 treatment of steroid- and OKT3-resistant rejection in renal transplant recipients 1997 ·Transplantation Proceedings ·Volker Kliem, D. Schaumann, (unknown), Oliver K. Eberhard, Volkmar Lufft, Hans J. Schlitt, R. Pichlmayr, Karl Koch, R. Brunkhorst	4
14	INCIDENCE OF Pneumocystis carinii PNEUMONIA AFTER RENAL TRANSPLANTATION 1996 ·Transplantation ·Volkmar Lufft, Volker Kliem, Matthias Behrend, R Pichlmayr, Karl Koch, R. Brunkhorst	68
15	Retention of Cytokine-lnducing Substances Inside High-Flux Dialyzers 1996 ·Blood Purification ·Volkmar Lufft, A. Mahiout, (unknown), Karl Koch, (unknown)	6
16	Induction of interleukin-1 and interleukin-1 receptor antagonist during contaminated in-vitro dialysis with whole blood 1996 ·Nephrology Dialysis Transplantation ·Ralf Schindler, S. Krautzig, Volkmar Lufft, Gerhard Lonnemann, A. Mahiout, M N Marra, Stanley Shaldon, Karl Koch	38
17	The role of plasma coating on the permeation of cytokine-inducing substances through dialyser membranes 1995 ·Nephrology Dialysis Transplantation ·Gerhard Lonnemann, Ralf Schindler, Volkmar Lufft, A. Mahiout, Stanley Shaldon, K. M. Koch	22
18	Cross-reactivity distinguishes serum and nephritogenic anti-DNA antibodies in human lupus from their natural counterparts in normal serum 1990 ·Journal of Autoimmunity ·Jorge Sabbaga, (unknown), Volkmar Lufft, Robert S. Schwartz, Michael P. Madaio	55

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact